In this study, we assessed the potential role of ATF4 in CB-839-induced pancreatic cancer cell resistance and explored strategies to enhance CB-839 efficacy in pancreatic cancer cells. This evidence concerns the gene ATF4 and familial pancreatic carcinoma.